Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Gross Profit (2016 - 2017)

Lisata Therapeutics' Gross Profit history spans 8 years, with the latest figure at -$119600.0 for Q1 2017.

  • For Q1 2017, Gross Profit fell 109.48% year-over-year to -$119600.0; the TTM value through Mar 2017 reached $2.8 million, up 173.47%, while the annual FY2016 figure was $4.1 million, 78.11% up from the prior year.
  • Gross Profit reached -$119600.0 in Q1 2017 per LSTA's latest filing, down from $931390.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.3 million in Q1 2016 to a low of -$6.2 million in Q4 2015.
  • Average Gross Profit over 5 years is -$890273.8, with a median of $124382.0 recorded in 2013.
  • Peak YoY movement for Gross Profit: crashed 3052.89% in 2014, then skyrocketed 1732.11% in 2016.
  • A 5-year view of Gross Profit shows it stood at $734049.0 in 2013, then crashed by 666.45% to -$4.2 million in 2014, then plummeted by 48.51% to -$6.2 million in 2015, then surged by 115.08% to $931390.0 in 2016, then crashed by 112.84% to -$119600.0 in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Gross Profit are -$119600.0 (Q1 2017), $931390.0 (Q4 2016), and $706265.0 (Q3 2016).